Create Medic Co., Ltd. (TYO:5187)
Japan
· Delayed Price · Currency is JPY 955.00
+4.00 (0.42%)
May 23, 2025, 3:22 PM JST
Create Medic Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 13,274 | 13,030 | 12,585 | 12,257 | 11,698 | 10,830 | Upgrade
|
| Revenue Growth (YoY) | 4.59% | 3.54% | 2.68% | 4.78% | 8.02% | -0.12% | Upgrade
|
| Cost of Revenue | 7,478 | 7,326 | 7,107 | 6,883 | 6,438 | 5,753 | Upgrade
|
| Gross Profit | 5,796 | 5,704 | 5,478 | 5,374 | 5,260 | 5,077 | Upgrade
|
| Selling, General & Admin | 4,980 | 5,011 | 4,675 | 4,636 | 4,393 | 4,092 | Upgrade
|
| Operating Expenses | 4,980 | 5,011 | 4,675 | 4,636 | 4,393 | 4,092 | Upgrade
|
| Operating Income | 816 | 693 | 803 | 738 | 867 | 985 | Upgrade
|
| Interest Expense | -11 | -10 | -10 | -7 | -6 | -7 | Upgrade
|
| Interest & Investment Income | 42 | 42 | 35 | 42 | 43 | 33 | Upgrade
|
| Currency Exchange Gain (Loss) | -8 | 3 | 26 | 26 | 84 | -60 | Upgrade
|
| Other Non Operating Income (Expenses) | 20 | 23 | 23 | 11 | 26 | 5 | Upgrade
|
| EBT Excluding Unusual Items | 859 | 751 | 877 | 810 | 1,014 | 956 | Upgrade
|
| Gain (Loss) on Sale of Investments | -29 | -29 | -24 | - | -75 | -3 | Upgrade
|
| Gain (Loss) on Sale of Assets | 268 | 297 | -5 | 4 | -5 | -4 | Upgrade
|
| Asset Writedown | -146 | -23 | - | - | - | - | Upgrade
|
| Other Unusual Items | 269 | 89 | 56 | 22 | 31 | 34 | Upgrade
|
| Pretax Income | 1,221 | 1,085 | 904 | 836 | 965 | 983 | Upgrade
|
| Income Tax Expense | 231 | 245 | 750 | 376 | 305 | 324 | Upgrade
|
| Net Income | 990 | 840 | 154 | 460 | 660 | 659 | Upgrade
|
| Net Income to Common | 990 | 840 | 154 | 460 | 660 | 659 | Upgrade
|
| Net Income Growth | 1078.57% | 445.46% | -66.52% | -30.30% | 0.15% | -9.10% | Upgrade
|
| Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade
|
| Shares Change (YoY) | -4.44% | -3.17% | 0.05% | 0.03% | -1.83% | -0.55% | Upgrade
|
| EPS (Basic) | 113.92 | 95.31 | 16.92 | 50.56 | 72.57 | 71.13 | Upgrade
|
| EPS (Diluted) | 113.92 | 95.31 | 16.92 | 50.56 | 72.57 | 71.13 | Upgrade
|
| EPS Growth | 1133.32% | 463.32% | -66.54% | -30.33% | 2.02% | -8.60% | Upgrade
|
| Free Cash Flow | - | 1,865 | 263 | 201 | 949 | 1,021 | Upgrade
|
| Free Cash Flow Per Share | - | 211.60 | 28.89 | 22.09 | 104.34 | 110.21 | Upgrade
|
| Dividend Per Share | 37.000 | 37.000 | 37.000 | 37.000 | 37.000 | 37.000 | Upgrade
|
| Gross Margin | 43.66% | 43.78% | 43.53% | 43.84% | 44.96% | 46.88% | Upgrade
|
| Operating Margin | 6.15% | 5.32% | 6.38% | 6.02% | 7.41% | 9.10% | Upgrade
|
| Profit Margin | 7.46% | 6.45% | 1.22% | 3.75% | 5.64% | 6.08% | Upgrade
|
| Free Cash Flow Margin | - | 14.31% | 2.09% | 1.64% | 8.11% | 9.43% | Upgrade
|
| EBITDA | 1,464 | 1,329 | 1,391 | 1,338 | 1,329 | 1,390 | Upgrade
|
| EBITDA Margin | 11.03% | 10.20% | 11.05% | 10.92% | 11.36% | 12.83% | Upgrade
|
| D&A For EBITDA | 648 | 636 | 588 | 600 | 462 | 405 | Upgrade
|
| EBIT | 816 | 693 | 803 | 738 | 867 | 985 | Upgrade
|
| EBIT Margin | 6.15% | 5.32% | 6.38% | 6.02% | 7.41% | 9.10% | Upgrade
|
| Effective Tax Rate | 18.92% | 22.58% | 82.97% | 44.98% | 31.61% | 32.96% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.